HPV Vaccine (Gardasil 9) from Japan
Recombinant vaccine preventing human papillomavirus infections that cause cervical cancer and warts. HTS 3002.41.00.00 covers this as a biotechnological human vaccine.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit Biologics License Application details and adverse event reporting plans
• Store and ship at 2-8°C; validate packaging for multi-dose vials